Select Bibliography

Filter by any of these (after searching):

Seisler, Drew

AUTHOR ABSTRACT DEADLINES

A meeting abstract must be submitted by the first or corresponding author to the Alliance Publications Coordinator (publications@AllianceNCTN.org) at least two weeks prior to the meeting abstract submission deadline. For detailed information about Alliance Publications guidelines, please refer to the policies, along with the author abstract deadlines.

There are 30 items

Effect of Vitamin D Supplementation on Breast Cancer Biomarkers: CALGB 70806 (Alliance) Study Design and Baseline Data

Apoe, Ogheneruona , Jung, Sin-Ho , Liu, Heshan , Seisler, Drew K ... - - Am J Hematol Oncol - 2016

Manuscript - Primary - Preliminary - Prevention - CALGB-70806

Effects of a lymphedema prevention intervention on range of motion among women receiving axillary node dissection for breast cancer treatment (Alliance) CALGB 70305

Armer, Jane M , Liu, Heshan , Oliveri, Jill , Seisler, Drew , tbd ... - ASCO CSS - J Clin Oncol - 2018

Abstract - Secondary - Primary - Symptom Inter - CALGB-70305

Feasibility Assessment of Patient Reporting of Symptomatic Adverse Events in Multicenter Cancer Clinical Trials

Basch, Ethan , Dueck, Amylou C. , Rogak, Lauren J. ... - - JAMA Oncol - 2017

Manuscript - Secondary-not-in-original - Meta-Analysis - Health Outcomes - CALGB-30607 , CALGB-30610 , CALGB-40502 , CALGB-40503 , CALGB-40601 , CALGB-70501 , CALGB-70604 , CALGB-80405 , CALGB-90401

Comparative nocebo findings in older patients enrolled in cancer therapeutic trials: observations from a 446-patient cohort (Alliance A151602)

Foster, Jared C. , Le-Rademacher, Jennifer G. ... - ASCO - J Clin Oncol - 2017

Abstract - Primary - Primary - Older Adult - A151602 , ACOSOG-Z9001 , NCCTG-97-24-51

Comparative “Nocebo Effects” in Older Patients Enrolled in Cancer Therapeutic Trials: Observations From a 446-Patient Cohort

Foster, Jared C. , Le-Rademacher, Jennifer G. ... - - Cancer - 2017

Manuscript - Primary - Primary - Older Adult - A151602 , ACOSOG-Z9001 , NCCTG-97-24-51

Accrual of Older Patients With Breast Cancer to Alliance Systemic Therapy Trials Over Time: Protocol A151527

Freedman, Rachel A. , Foster, Jared C. , Seisler, Drew K. ... - - J Clin Oncol - 2017

Manuscript - Primary - Primary - Older Adult - A151527 , ACOSOG-Z1031 , ACOSOG-Z1041 , C8541 , C9344 , C9741 , CALGB-40101 , CALGB-40302 , CALGB-40502 , CALGB-40503 , CALGB-40601 , CALGB-40603 , CALGB-49907 , CALGB-9342 , CALGB-9840 , N89-30-52 , N9831

Accrual of Older Breast Cancer Patients to Alliance Systemic Therapy Protocols over Time: Alliance A151527

Freedman, Rachel A , Seisler, Drew K. , Foster, Jared C. ... - ASCO - J Clin Oncol - 2016

Abstract - Primary - Primary - Older Adult - A151527 , ACOSOG-Z1031 , ACOSOG-Z1041 , C8541 , C9344 , C9741 , CALGB-40101 , CALGB-40302 , CALGB-40502 , CALGB-40503 , CALGB-40601 , CALGB-40603 , CALGB-49907 , CALGB-9342 , CALGB-9840 , N89-30-52 , N9831

Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients With Bone Metastases

Himelstein, Andrew L. , Foster, Jared C. , Khatcheressian, James L. ... - - JAMA - 2017

Manuscript - Primary - Primary - Symptom Inter - CALGB-79804 , CALGB-70604 , CALGB-150804

CALGB 70604 (Alliance): A randomized phase III study of standard dosing vs. longer interval dosing of zoledronic acid in metastatic cancer

Himelstein, Andrew L. , Qin, Rui , Novotny, Paul J. ... - ASCO - J Clin Oncol - 2015

Abstract - Primary - Primary - Symptom Inter - CALGB-70604

Geriatric assessment among older adults receiving intensive therapy for acute myeloid leukemia: Report of CALGB 361006 (Alliance).

Klepin, Heidi D , Ritchie, Ellen , Major-Elechi, Brittny ... - - J Geriatr Oncol - 2020

Manuscript - Primary - Primary - Older Adult - CALGB-361006

Comparison of results from three different density assessment methods on mammographic density (MD) in a screening patients receiving vitamin D (Vit D): Results of CALGB 70806 (Alliance)

Le-Petross, Huong T. , Seisler, Drew K. , Kontos, Despina ... - RSNA - - 2018

Abstract - Secondary - Primary - Prevention - CALGB-70806

Patient-Reported (EORTC QLQ-CIPN20) Versus Physician-Reported (CTCAE) Quantification of Oxaliplatin- and Paclitaxel/Carboplatin-Induced Peripheral Neuropathy in NCCTG/Alliance Clinical Trials

Le-Rademacher, Jennifer , Kanwar, Rahul , Seisler, Drew ... - - Support Care Cancer - 2017

Manuscript - Secondary-not-in-original - Meta-Analysis - Symptom Inter - N08CA , N08CB

Phase III Randomized, Placebo-Controlled, Double-Blind Study of Intravenous Calcium and Magnesium to Prevent Oxaliplatin-Induced Sensory Neurotoxicity (N08CB/Alliance)

Loprinzi, Charles L. , Qin, Rui , Dakhil, Shaker R. ... - - J Clin Oncol - 2014

Manuscript - Primary - Primary - Symptom Inter - N08CB

Health-Related Quality of Life Outcomes for the LEAP Study - CALGB 70305 (Alliance): A Lymphedema Prevention Intervention Trial for Newly Diagnosed Breast Cancer Patients

Naughton, Michelle J. , Liu, Heshan , Seisler, Drew ... - - Cancer - 2021

Manuscript - Secondary - Primary - Health Outcomes - CALGB-70305

Clinical course of patients with oxaliplatin-associated neuropathy: N08CB (Alliance)

Pachman, Deirdre R. , Qin, Rui , Seisler, Drew K. ... - ASCO - J Clin Oncol - 2014

Abstract - Secondary - Primary - Symptom Inter - N08CB

Clinical Course of Oxaliplatin-Induced Neuropathy: Results From the Randomized Phase III Trial N08CB (Alliance)

Pachman, Deirdre R. , Qin, Rui , Seisler, Drew K. , Smith, Ellen M.L. ... - - J Clin Oncol - 2015

Manuscript - Secondary - Primary - Symptom Inter - N08CB

Comparison of oxaliplatin and paclitaxel-induced neuropathy (Alliance A151505)

Pachman, Deirdre R. , Qin, Rui , Seisler, Drew ... - - Support Care Cancer - 2016

Manuscript - Primary - Primary - Symptom Inter - A151505 , N08C1 , N08CB

Effect of a Behavioral Intervention to Increase Vegetable Consumption on Cancer Progression Among Men With Early-Stage Prostate Cancer

Parsons, J. Kellogg , Zahrieh, David , Mohler, James L. ... - - JAMA - 2020

Manuscript - Primary - Primary - Prevention - CALGB-70807

A randomized study to prevent lymphedema in women treated for breast cancer: CALGB 70305 (Alliance)

Paskett, Electra D. , Le-Rademacher, Jennifer , Oliveri, Jill M. ... - - Cancer - 2021

Manuscript - Primary - Primary - Symptom Inter - CALGB-70305

The LEAP Study: Effects of a lymphedema prevention intervention on swelling, range of motion and quality of life (Alliance)

Paskett, Electra D. , Le-Rademacher, Jennifer , Oliveri, Jill ... - IPOS - Psycho-Oncol - 2018

Abstract - Primary - Primary - Symptom Inter - CALGB-70305

Effects of a lymphedema prevention intervention on range of motion among women receiving lymph node dissection for breast cancer treatment (Alliance) CALGB 70305.

Paskett, Electra D. , Liu, Heshan , Oliveri, Jill , Seisler, Drew K. ... - ILF - JCO - 2018

Abstract - Secondary - Primary - Symptom Inter - CALGB-70305

Prevention of Lymphedema in Women with Breast Cancer: Results of CALGB 70305 (Alliance)

Paskett, Electra , Oliveri, Jill , Le-Rademacher, Jennifer ... - ASCO CSS - J Clin Oncol - 2017

Abstract - Primary - Primary - Symptom Inter - CALGB-70305

A Comparison of the Natural History of Oxaliplatin- and Paclitaxel-Induced Neuropathy (NCCTG N08C1, N08CB/Alliance)

Ruddy, Kathryn Jean , Pachman, Dierdre , Qin, Rui , Seisler, Drew K. ... - ASCO - J Clin Oncol - 2015

Abstract - Primary - Primary - Symptom Inter - A151505 , N08C1 , N08CB

Repeated Measures Analyses of Dermatitis Symptom Evolution in Breast Cancer Patients Receiving Radiotherapy in a Phase 3 Randomized Trial of Mometasone Furoate vs Placebo (N06C4 [Alliance])

Sio, Terence T. , Atherton, Pamela J. , Birckhead, Brandon J ... - - Support Care Cancer - 2016

Manuscript - Secondary - Primary - Symptom Inter - N06C4

Frequency and impact of grade three or four toxicities of novel agents on outcomes of older patients with chronic lymphocytic leukemia and non-Hodgkin lymphoma (alliance A151611)☆

Tallarico, Michael , Foster, Jared C. , Seisler, Drew ... - - J Geriatr Oncol - 2018

Manuscript - Secondary - Primary - Older Adult - A151611

Toxicities and related outcomes of elderly patients (≥65 years) with hematologic malignancies in the contemporary era (Alliance A151611)

Tallarico, Michael , Foster, Jared , Seisler, Drew ... - ASH - Blood - 2016

Abstract - Primary - Primary - Older Adult - A151611 , CALGB-10101 , CALGB-10404 , CALGB-10501 , CALGB-19805 , CALGB-19901 , CALGB-50002 , CALGB-50103 , CALGB-50201 , CALGB-50401 , CALGB-50402 , CALGB-50501 , CALGB-50602 , CALGB-50701 , CALGB-50803

Influence of vitamin D (Vit D) on mammographic density (MD) and insulin like growth factor 1 (IGF1): results of CALGB (Alliance) 70806

Wood, Marie , Seisler, Drew K. , Hsieh, Meng-Kang , Kontos, Despina ... - ASCO - J Clin Oncol - 2018

Abstract - Primary - Primary - Prevention - CALGB-70806

Venlafaxine to prevent oxaliplatin-induced neuropathy?: A pilot randomized placebo-controlled trial.

Zimmerman, Collin Thomas , Atherton, Pamela J. , Pachman, Deirdre R. ... - ASCO - J Clin Oncol - 2015

Abstract - Primary - Primary - Symptom Inter - NCT01611155

Venlafaxine to Prevent Oxaliplatin-Induced Neuropathy? A Pilot Randomized Placebo Controlled Trial

Zimmerman, Collin , Atherton, Pam , Pachman, Deirdre , Seisler, Drew ... - MASCC / ISOO - Support Care Cancer - 2015

Abstract - Primary - Primary - Symptom Inter - NCT01611155

MC11C4: a pilot randomized, placebo-controlled, double-blind study of venlafaxine to prevent oxaliplatin-induced neuropathy

Zimmerman, Collin , Atherton, Pamela J. , Pachman, Deirdre ... - - Support Care Cancer - 2016

Manuscript - Primary - Primary - Symptom Inter - NCT01611155